台股 » 個股 » 東生華 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

東生華

(8432)
可現股當沖
  • 股價
    59.0
  • 漲跌
    ▲0.1
  • 漲幅
    +0.17%
  • 成交量
    76
  • 產業
    上櫃 生技醫療類股
  • 36人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
東生華 (8432)籌碼相關-元大-羅東 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-羅東 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/08/14156.5000.0056.2011930.52%
2024/08/0200.00064.7063.2002210.00%
2024/07/08164.1000.0063.5012290.44%
2024/07/03169.00168.9068.9002250.00%
2024/06/1700.00163.1063.40-1219-0.45%
2024/06/14263.9500.0063.5022190.91%
2024/06/12264.9000.0064.2022200.91%
2024/06/1100.00167.1066.70-1217-0.46%
2024/06/06266.0000.0067.1022170.92%
2024/05/21167.1000.0066.3012890.34%
2024/04/03158.80160.1060.1002550.00%
2024/04/02061.0000.0058.8002540.00%
2024/03/29157.50157.2057.2002540.00%
2024/03/27258.20258.3058.3002540.00%
2024/02/2200.00161.0060.00-1193-0.52%
2024/02/21161.7000.0061.9011820.55%
2023/11/2800.00150.7050.80-1375-0.27%
2023/11/2400.002051.0850.60-20366-5.46%
2023/11/1500.00150.1050.10-1339-0.29%
2023/11/132050.0000.0050.30203276.10%
2023/11/08156.30155.6056.4002780.00%
2023/11/03153.0000.0052.0011730.58%
2023/05/03146.1500.0046.101571.74%
2023/02/0600.00047.5047.80081-0.02%
2022/09/1300.00149.5050.60-1280-0.36%
2022/09/07149.20148.6048.8002720.00%
2022/09/06149.4500.0048.6512670.37%
2022/09/05450.31450.0949.0002540.00%
2022/08/2500.001345.5445.20-13207-6.26%
2022/07/29245.98245.6344.9501300.00%
2022/07/28145.10144.2044.2001130.00%
2022/07/25147.95147.1547.950800.00%
2022/04/0600.00143.2043.25-140-2.46%
2022/03/28942.99942.7343.000420.00%
2022/03/16042.0000.0042.000430.01%
2022/03/04044.3500.0043.950430.02%
2022/03/03044.4000.0044.350430.00%
2022/02/2300.00543.9144.00-538-13.04%
2021/11/231344.5200.0043.95139713.40%
2021/10/2600.00446.3646.35-483-4.77%
2021/10/25147.75147.9047.500800.00%
2021/10/21545.57446.9045.301691.43%
2021/09/08439.4300.0039.204715.60%
2021/06/29242.9000.0042.9522380.84%
2021/05/19945.53943.4843.5001670.00%
2021/05/1800.00140.8545.15-1140-0.71%
2021/05/14143.0000.0042.4011370.73%
2021/04/15351.5300.0051.503873.45%
2020/10/1300.00268.0068.00-250-3.97%
2020/07/08267.0000.0066.802852.35%
2020/06/08169.50168.7068.700560.00%
2019/08/0700.00375.2075.20-339-7.58%
2019/08/06375.4000.0075.403397.63%
2018/08/1500.00285.0088.60-2170-1.17%
2018/08/10188.6000.0086.0011640.61%
2018/08/0700.00187.2088.30-1151-0.66%
2018/08/06190.5000.0090.5011510.66%
2018/08/0300.00190.0089.20-1150-0.66%
2018/08/01287.6500.0089.2021481.35%
2018/07/06181.60180.7080.7003890.00%
2018/07/02179.90179.4079.4004070.00%
2018/04/3000.00176.5076.70-1426-0.23%
2018/04/26291.40192.3089.0014090.24%
2018/04/2500.00199.6090.00-1384-0.26%
2018/04/24196.00194.5093.3003330.00%
2018/04/23190.30190.5093.8002980.00%
2018/04/20190.20190.8085.3002750.00%
2018/04/19186.00187.8086.9002660.00%
2018/04/17181.5000.0081.1012440.41%
2018/04/1600.00179.8077.20-1232-0.43%
2018/04/13183.7000.0082.9012220.45%
2018/01/17167.10167.7065.100770.00%
東生華液態切片技術新突破 成功識別92%肺癌基因突變Anue鉅亨-2024/08/26
東生華攜手陽明交大簽署MOU 聚焦人才培育、精準藥物開發Anue鉅亨-2024/07/22
東生華法說會/併購高峰、三大業務加持 今年營收拚增五成達12億UDN聯合新聞網-2024/03/25
東生華 相關文章